Form D · Biotechnology
Healthcare Integrated Technologies Inc.
Knoxville, TN · CIK 0001584693
Offering snapshot reported Nov 4, 2024 · SEC filing
- Reported sold
- $2.55M Indefinite offering
- Investors reported
- 20 Form D · investor count
- Minimum accepted
- $100K Reported outside-investor minimum
- First sale
- Jul 15, 2024 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Nov 4, 2024 | Initial | $2,552,000 | No comparison | 20 | SEC filing |
| Mar 14, 2018 | Initial | $7,668,000 | No comparison | 17 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-528526
Source: Form D, filed Nov 4, 2024. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| G. Shayne Bench | Director |
| Scott M. Boruff | Director, Executive |
| Timothy R. Brady | Executive |
| Micheal J. Burt | Director |
| Kenneth M. Greenwood | Executive |
| Dustin M. Hillis | Executive |
| Ryan E. Holland | Director |
| Susan A. Reyes | Executive |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
311 S. Weisgarber Road
Knoxville, TN, 37919
Knoxville, TN, 37919